Phase III Vehicle-Controlled, Multi-Centered Study of Topical Alitretinoin Gel 0.1% in Cutaneous AIDS-Related Kaposi's Sarcoma | American Journal of Clinical Dermatology
Can Median Nail Dystrophy be an Adverse Effect of Alitretinoin Treatment? | HTML | Acta Dermato-Venereologica
Alitretinoin can be a good treatment option for idiopathic recalcitrant trachyonychia in adults: an open‐label study - Shin - 2018 - Journal of the European Academy of Dermatology and Venereology - Wiley Online Library
Response to Treatment With Oral Alitretinoin in Patients With Chronic Hand Eczema That Is Refractory to Treatment With Potent Topical Corticosteroids: Experience in 15 Patients - ScienceDirect
Panretin gel Panretin® (alitretinoin) gel 0.1% (For topical use only) Rx only
Alitretinoin - Wikipedia
Phase III Vehicle-Controlled, Multi-Centered Study of Topical Alitretinoin Gel 0.1% in Cutaneous AIDS-Related Kaposi's Sarcoma | American Journal of Clinical Dermatology
Alitretinoin Therapeutic Cheat Sheet - Next Steps in Dermatology
PDF] Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel: results of phase 1 and 2 trials. | Semantic Scholar
Alitretinoin - wikidoc
ПАНРЕТИН гель (Алитретиноин) (PANRETIN gel (Alitretinoin)) - поиск и резервирование лекарств в России
Wisconsin Medicaid Update 99-49
PDF] Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel: results of phase 1 and 2 trials. | Semantic Scholar
NDC Package 59212-601-22 Panretin Gel Topical
Uses of Alitretinoin | Vinmec
Alitretinoin Gel in AIDS-Related Kaposi Sarcoma | Download Table